(646058, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646059, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646060, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646061, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646062, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646063, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646064, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646065, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646066, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646067, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646068, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646069, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646070, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646071, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646072, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646073, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646074, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646075, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646076, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646077, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646078, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646079, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646080, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646081, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646082, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646083, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646084, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646085, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646086, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646087, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646088, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646089, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646090, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646091, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646092, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646093, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646094, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646095, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646096, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646097, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646098, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646099, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646100, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646101, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646102, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646103, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646104, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646105, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646106, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646107, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646108, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646109, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646110, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646111, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646112, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646113, 'HP:0034076', 'Anti-ribosome Po antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646114, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011885', 'abnormal circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646115, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012327', 'abnormal circulating factor VIII level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646116, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0002965', 'increased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646117, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012622', 'increased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646118, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646119, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0001560', 'abnormal circulating insulin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646120, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646121, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005419', 'decreased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646122, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646123, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005667', 'abnormal circulating leptin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646124, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646125, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646126, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012621', 'decreased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646127, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031107', 'abnormal circulating myoglobin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646128, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020248', 'decreased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646129, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020257', 'increased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646130, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646131, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020247', 'increased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646132, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646133, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031082', 'decreased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646134, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0008820', 'abnormal blood uric acid level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646135, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010209', 'abnormal circulating chemokine level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646136, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012330', 'decreased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646137, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646138, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646139, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0000188', 'abnormal circulating glucose level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(646140, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031108', 'increased circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646141, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646142, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010091', 'decreased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646143, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012223', 'increased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646144, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031243', 'abnormal circulating CSF3 level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646145, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646146, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646147, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646148, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031077', 'increased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646149, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646150, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646151, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646152, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031079', 'increased circulating troponin I level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646153, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010210', 'abnormal circulating cytokine level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646154, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646155, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0008548', 'abnormal circulating interferon level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646156, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0009699', 'hyperchylomicronemia', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646157, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031083', 'increased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646158, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012329', 'increased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646159, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0008588', 'abnormal circulating interleukin level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646160, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012617', 'abnormal circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646161, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012333', 'increased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646162, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005311', 'abnormal circulating amino acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646163, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646164, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011887', 'decreased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646165, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646166, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646167, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011894', 'decreased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646168, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646169, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011888', 'abnormal circulating total protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646170, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0002941', 'increased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646171, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646172, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646173, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0030624', 'abnormal circulating cysteine level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646174, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646175, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012328', 'decreased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646176, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0013403', 'abnormal circulating lactate level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(646177, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646178, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646179, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646180, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010215', 'abnormal circulating complement protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646181, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646182, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646183, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646184, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011892', 'abnormal circulating transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646185, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012326', 'increased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646186, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020216', 'decreased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646187, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0008806', 'increased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646188, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646189, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646190, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012331', 'increased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646191, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646192, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031076', 'decreased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646193, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020256', 'abnormal circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646194, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0030745', 'increased circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646195, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646196, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010090', 'increased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646197, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005308', 'abnormal circulating ammonia level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646198, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012324', 'abnormal circulating antithrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646199, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020246', 'abnormal circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646200, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012325', 'decreased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646201, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012666', 'increased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646202, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012620', 'abnormal circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646203, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0003349', 'abnormal circulating renin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646204, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020985', 'increased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646205, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020984', 'decreased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646206, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646207, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646208, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012332', 'decreased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646209, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012615', 'decreased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646210, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646211, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012619', 'increased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646212, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646213, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646214, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0008805', 'decreased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646215, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020983', 'abnormal circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646216, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646217, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646218, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646219, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012616', 'increased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646220, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031081', 'abnormal circulating D-dimer level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646221, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031065', 'increased circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646222, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646223, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646224, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011893', 'increased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646225, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012614', 'abnormal circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646226, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031078', 'increased circulating troponin T level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646227, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011891', 'decreased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646228, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646229, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011889', 'abnormal circulating ferritin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646230, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012664', 'decreased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646231, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005416', 'abnormal circulating protein level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646232, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646233, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0008804', 'abnormal circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646234, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646235, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020217', 'increased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646236, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020255', 'absent circulating factor XII protein', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646237, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646238, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0004730', 'abnormal circulating gastrin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646239, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646240, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646241, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031059', 'increased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646242, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0030757', 'abnormal circulating histamine level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646243, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0005567', 'decreased circulating total protein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646244, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646245, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0013257', 'decreased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646246, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646247, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0020258', 'decreased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646248, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646249, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012222', 'decreased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646250, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0013256', 'increased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646251, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646252, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646253, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031075', 'abnormal circulating troponin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646254, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011890', 'increased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646255, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0001570', 'abnormal circulating enzyme level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646256, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0013255', 'abnormal circulating thrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646257, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011886', 'increased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646258, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646259, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0011912', 'abnormal circulating fibronectin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646260, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0002695', 'abnormal circulating glucagon level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646261, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012618', 'decreased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646262, 'HP:0032094', 'Increased circulating surfactant protein level', 'MP:0012221', 'abnormal circulating prothrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646263, 'HP:0010866', 'Abdominal wall defect', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(646264, 'HP:0010866', 'Abdominal wall defect', 'MP:0030579', 'thoracoabdominoschisis', 0.40625, 13.022184767190119, 2.300057077915891, 'UPHENO:0075684', 'abnormal abdominal wall'),
(646265, 'HP:0010866', 'Abdominal wall defect', 'MP:0003052', 'omphalocele', 0.40625, 13.022184767190119, 2.300057077915891, 'UPHENO:0075684', 'abnormal abdominal wall'),
(646266, 'HP:0010866', 'Abdominal wall defect', 'MP:0003258', 'hiatal hernia', 0.40625, 13.022184767190119, 2.300057077915891, 'UPHENO:0075684', 'abnormal abdominal wall'),
(646267, 'HP:0010866', 'Abdominal wall defect', 'MP:0003257', 'abnormal abdominal wall morphology', 0.41935483870967744, 13.022184767190119, 2.3368603280240414, 'UPHENO:0075684', 'abnormal abdominal wall'),
(646268, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0000613', 'abnormal salivary gland morphology', 0.4230769230769231, 11.592196926445306, 2.2145859674761432, 'UPHENO:0076751', 'abnormal saliva-secreting gland morphology'),
(646269, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0013818', 'abnormal oral cavity morphology', 0.425531914893617, 9.27922043240247, 1.987109569027385, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(646270, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0021164', 'oral cleft', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(646271, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0009517', 'abnormal salivary gland duct morphology', 0.4074074074074074, 11.592196926445306, 2.1731881869638436, 'UPHENO:0076751', 'abnormal saliva-secreting gland morphology'),
(646272, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0000617', 'increased salivary gland mucosal cell number', 0.41509433962264153, 11.592196926445306, 2.193594157531978, 'UPHENO:0076751', 'abnormal saliva-secreting gland morphology'),
(646273, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0003792', 'abnormal major salivary gland morphology', 0.4074074074074074, 11.592196926445306, 2.1731881869638436, 'UPHENO:0076751', 'abnormal saliva-secreting gland morphology'),
(646274, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0030606', 'abnormal gingival sulcus moprhology', 0.40816326530612246, 9.27922043240247, 1.9461338369147898, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(646275, 'HP:0010286', 'Abnormal salivary gland morphology', 'MP:0000452', 'abnormal mouth morphology', 0.41304347826086957, 7.503859459499253, 1.760517029605877, 'UPHENO:0076800', 'abnormal mouth morphology'),
(646276, 'HP:0002908', 'Conjugated hyperbilirubinemia', 'MP:0005344', 'increased circulating bilirubin level', 0.5, 15.192109768632433, 2.75609413560499, 'UPHENO:0068320', 'increased level of bilirubin IXalpha in blood'),
(646277, 'HP:0030997', 'Atretic vas deferens', 'MP:0031209', 'enlarged cauda epididymis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646278, 'HP:0030997', 'Atretic vas deferens', 'MP:0004935', 'epididymis degeneration', 0.45454545454545453, 10.371930806217245, 2.1712931637220296, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646279, 'HP:0030997', 'Atretic vas deferens', 'MP:0014187', 'spermatocele', 0.4358974358974359, 10.371930806217245, 2.1262873850295314, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646280, 'HP:0030997', 'Atretic vas deferens', 'MP:0004926', 'abnormal epididymis size', 0.46511627906976744, 10.371930806217245, 2.196395652735831, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646281, 'HP:0030997', 'Atretic vas deferens', 'MP:0009140', 'dilated efferent ductule of testis', 0.43478260869565216, 10.371930806217245, 2.1235666067109675, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646282, 'HP:0030997', 'Atretic vas deferens', 'MP:0004930', 'small epididymis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646283, 'HP:0030997', 'Atretic vas deferens', 'MP:0004927', 'abnormal epididymis weight', 0.43478260869565216, 10.371930806217245, 2.1235666067109675, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646284, 'HP:0030997', 'Atretic vas deferens', 'MP:0031211', 'small corpus epididymis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646285, 'HP:0030997', 'Atretic vas deferens', 'MP:0004728', 'abnormal efferent ductules of testis morphology', 0.425, 10.371930806217245, 2.0995405670389724, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646286, 'HP:0030997', 'Atretic vas deferens', 'MP:0014188', 'epididymis fibrosis', 0.46511627906976744, 10.371930806217245, 2.196395652735831, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646287, 'HP:0030997', 'Atretic vas deferens', 'MP:0010145', 'abnormal spermatic cord morphology', 0.425, 10.371930806217245, 2.0995405670389724, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646288, 'HP:0030997', 'Atretic vas deferens', 'MP:0031210', 'small cauda epididymis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646289, 'HP:0030997', 'Atretic vas deferens', 'MP:0009256', 'enlarged corpus epididymis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646290, 'HP:0030997', 'Atretic vas deferens', 'MP:0002631', 'abnormal epididymis morphology', 0.425, 10.371930806217245, 2.0995405670389724, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646291, 'HP:0030997', 'Atretic vas deferens', 'MP:0009207', 'internal male genitalia hypoplasia', 0.43478260869565216, 10.371930806217245, 2.1235666067109675, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646292, 'HP:0030997', 'Atretic vas deferens', 'MP:0004931', 'enlarged epididymis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646293, 'HP:0030997', 'Atretic vas deferens', 'MP:0004933', 'abnormal epididymis epithelium morphology', 0.40476190476190477, 10.371930806217245, 2.0489417925317377, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646294, 'HP:0030997', 'Atretic vas deferens', 'MP:0002769', 'abnormal vas deferens morphology', 0.40476190476190477, 10.371930806217245, 2.0489417925317377, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646295, 'HP:0030997', 'Atretic vas deferens', 'MP:0009205', 'abnormal internal male genitalia morphology', 0.4473684210526316, 10.371930806217245, 2.1540831711065747, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646296, 'HP:0030997', 'Atretic vas deferens', 'MP:0009198', 'abnormal male genitalia morphology', 0.40540540540540543, 9.321745049049028, 1.9439870963294874, 'UPHENO:0087802', 'abnormal male reproductive organ morphology'),
(646297, 'HP:0030997', 'Atretic vas deferens', 'MP:0002660', 'abnormal caput epididymis morphology', 0.40476190476190477, 10.371930806217245, 2.0489417925317377, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646298, 'HP:0030997', 'Atretic vas deferens', 'MP:0002662', 'abnormal cauda epididymis morphology', 0.40476190476190477, 10.371930806217245, 2.0489417925317377, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646299, 'HP:0030997', 'Atretic vas deferens', 'MP:0002661', 'abnormal corpus epididymis morphology', 0.40476190476190477, 10.371930806217245, 2.0489417925317377, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646300, 'HP:0030997', 'Atretic vas deferens', 'MP:0009249', 'enlarged caput epididymis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646301, 'HP:0030997', 'Atretic vas deferens', 'MP:0004934', 'epididymis epithelium degeneration', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(646302, 'HP:0034952', 'Gangliocytoma', 'MP:0003864', 'abnormal midbrain development', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646303, 'HP:0034952', 'Gangliocytoma', 'MP:0008026', 'abnormal brain white matter morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646304, 'HP:0034952', 'Gangliocytoma', 'MP:0010744', 'abnormal cervical flexure morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646305, 'HP:0034952', 'Gangliocytoma', 'MP:0021002', 'brain lesion', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(646306, 'HP:0034952', 'Gangliocytoma', 'MP:0013935', 'basal brain tissue herniation', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(646307, 'HP:0034952', 'Gangliocytoma', 'MP:0000913', 'abnormal brain development', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646308, 'HP:0034952', 'Gangliocytoma', 'MP:0006108', 'abnormal hindbrain development', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646309, 'HP:0034952', 'Gangliocytoma', 'MP:0000841', 'abnormal hindbrain morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646310, 'HP:0034952', 'Gangliocytoma', 'MP:0000914', 'exencephaly', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646311, 'HP:0034952', 'Gangliocytoma', 'MP:0005277', 'abnormal brainstem morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646312, 'HP:0034952', 'Gangliocytoma', 'MP:0000955', 'abnormal spinal cord morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646313, 'HP:0034952', 'Gangliocytoma', 'MP:0010892', 'increased oligodendrocyte progenitor number', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646314, 'HP:0034952', 'Gangliocytoma', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646315, 'HP:0034952', 'Gangliocytoma', 'MP:0003214', 'neurofibrillary tangles', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646316, 'HP:0034952', 'Gangliocytoma', 'MP:0000783', 'abnormal forebrain morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646317, 'HP:0034952', 'Gangliocytoma', 'MP:0000778', 'abnormal nervous system tract morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646318, 'HP:0034952', 'Gangliocytoma', 'MP:0001889', 'delayed brain development', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646319, 'HP:0034952', 'Gangliocytoma', 'MP:0005157', 'holoprosencephaly', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646320, 'HP:0034952', 'Gangliocytoma', 'MP:0000954', 'decreased oligodendrocyte progenitor number', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646321, 'HP:0034952', 'Gangliocytoma', 'MP:0004250', 'tau protein deposits', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(646322, 'HP:0034952', 'Gangliocytoma', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646323, 'HP:0034952', 'Gangliocytoma', 'MP:0008025', 'brain vacuoles', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646324, 'HP:0034952', 'Gangliocytoma', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(646325, 'HP:0034952', 'Gangliocytoma', 'MP:0002152', 'abnormal brain morphology', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(646326, 'HP:0040264', 'Jaw pain', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646327, 'HP:0040264', 'Jaw pain', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646328, 'HP:0040264', 'Jaw pain', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646329, 'HP:0040264', 'Jaw pain', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646330, 'HP:0040264', 'Jaw pain', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646331, 'HP:0040264', 'Jaw pain', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646332, 'HP:0040264', 'Jaw pain', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646333, 'HP:0040264', 'Jaw pain', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(646334, 'HP:0040264', 'Jaw pain', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646335, 'HP:0040264', 'Jaw pain', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646336, 'HP:0040264', 'Jaw pain', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646337, 'HP:0040264', 'Jaw pain', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646338, 'HP:0040264', 'Jaw pain', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646339, 'HP:0040264', 'Jaw pain', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646340, 'HP:0040264', 'Jaw pain', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646341, 'HP:0040264', 'Jaw pain', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646342, 'HP:0040264', 'Jaw pain', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646343, 'HP:0040264', 'Jaw pain', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(646344, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012223', 'increased circulating prothrombin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646345, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011611', 'abnormal circulating ghrelin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646346, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012332', 'decreased circulating fibronectin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646347, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646348, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646349, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012328', 'decreased circulating factor VIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646350, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646351, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0008820', 'abnormal blood uric acid level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646352, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020258', 'decreased circulating factor XII level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646353, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646354, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020247', 'increased circulating arginase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646355, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646356, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005419', 'decreased circulating serum albumin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646357, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0013256', 'increased circulating thrombin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646358, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646359, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646360, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646361, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646362, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646363, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020248', 'decreased circulating arginase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646364, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031079', 'increased circulating troponin I level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646365, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646366, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011886', 'increased circulating lipase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646367, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646368, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011893', 'increased circulating transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646369, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011890', 'increased circulating ferritin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646370, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646371, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005311', 'abnormal circulating amino acid level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646372, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646373, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020984', 'decreased circulating factor XI level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646374, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646375, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012622', 'increased circulating factor XIII level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646376, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646377, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031065', 'increased circulating procalcitonin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646378, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020983', 'abnormal circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646379, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646380, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031077', 'increased circulating troponin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646381, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646382, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646383, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646384, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646385, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0008804', 'abnormal circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646386, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646387, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012329', 'increased circulating factor VIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646388, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0002941', 'increased circulating alanine transaminase level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646389, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646390, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646391, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646392, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010091', 'decreased circulating creatine kinase level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646393, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646394, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646395, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646396, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646397, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646398, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0003349', 'abnormal circulating renin level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646399, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012325', 'decreased circulating antithrombin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646400, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012666', 'increased circulating haptoglobin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646401, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646402, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011892', 'abnormal circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646403, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0004730', 'abnormal circulating gastrin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646404, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005667', 'abnormal circulating leptin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646405, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0000199', 'abnormal circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646406, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012222', 'decreased circulating prothrombin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646407, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646408, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012616', 'increased circulating factor IX level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646409, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011891', 'decreased circulating ferritin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646410, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020246', 'abnormal circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646411, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646412, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012618', 'decreased circulating factor X level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646413, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031082', 'decreased circulating D-dimer level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646414, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646415, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011894', 'decreased circulating transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646416, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005416', 'abnormal circulating protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646417, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012333', 'increased circulating fibronectin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646418, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020255', 'absent circulating factor XII protein', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646419, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0008806', 'increased circulating amylase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646420, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646421, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0013257', 'decreased circulating thrombin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646422, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031076', 'decreased circulating troponin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646423, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011885', 'abnormal circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646424, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646425, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0001570', 'abnormal circulating enzyme level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646426, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011888', 'abnormal circulating total protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646427, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0002965', 'increased circulating serum albumin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646428, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646429, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012621', 'decreased circulating factor XIII level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646430, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646431, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012619', 'increased circulating factor X level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646432, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646433, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011887', 'decreased circulating lipase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646434, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646435, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646436, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646437, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010210', 'abnormal circulating cytokine level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646438, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020985', 'increased circulating factor XI level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646439, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020257', 'increased circulating factor XII level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646440, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005567', 'decreased circulating total protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646441, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646442, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011889', 'abnormal circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646443, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031083', 'increased circulating D-dimer level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646444, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646445, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646446, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646447, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012617', 'abnormal circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646448, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646449, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0010090', 'increased circulating creatine kinase level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646450, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646451, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005308', 'abnormal circulating ammonia level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646452, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0013255', 'abnormal circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646453, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646454, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012326', 'increased circulating antithrombin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646455, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031078', 'increased circulating troponin T level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646456, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012615', 'decreased circulating factor IX level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646457, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012614', 'abnormal circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646458, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646459, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646460, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031108', 'increased circulating myoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646461, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0030757', 'abnormal circulating histamine level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(646462, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646463, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0008805', 'decreased circulating amylase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646464, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031075', 'abnormal circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646465, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0020256', 'abnormal circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646466, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646467, 'HP:0031300', 'Abnormal circulating properdin level', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(646468, 'HP:0000935', 'Thickened cortex of long bones', 'MP:0000134', 'abnormal compact bone thickness', 0.42857142857142855, 13.732678149995134, 2.425991239237079, 'UPHENO:0085703', 'abnormal compact bone tissue thickness'),
(646469, 'HP:0000935', 'Thickened cortex of long bones', 'MP:0010929', 'increased osteoid thickness', 0.41509433962264153, 9.62605573046134, 1.9989300254402589, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(646470, 'HP:0000935', 'Thickened cortex of long bones', 'MP:0000132', 'thickened long bone epiphysis', 0.40350877192982454, 9.62605573046134, 1.9708368593890528, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(646471, 'HP:0000935', 'Thickened cortex of long bones', 'MP:0010973', 'increased periosteum thickness', 0.4117647058823529, 9.62605573046134, 1.9908967845321746, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(646472, 'HP:0000935', 'Thickened cortex of long bones', 'MP:0009347', 'increased trabecular bone thickness', 0.41509433962264153, 9.62605573046134, 1.9989300254402589, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(646473, 'HP:0000935', 'Thickened cortex of long bones', 'MP:0004148', 'increased compact bone thickness', 0.52, 14.491670050491338, 2.7451171971803854, 'UPHENO:0047876', 'increased thickness of the compact bone tissue'),
(646474, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646475, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646476, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646477, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646478, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646479, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646480, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646481, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646482, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646483, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646484, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646485, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646486, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646487, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646488, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646489, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646490, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646491, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646492, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646493, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646494, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646495, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646496, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646497, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646498, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646499, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646500, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646501, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646502, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646503, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646504, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646505, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646506, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646507, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646508, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646509, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646510, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646511, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646512, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646513, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646514, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646515, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646516, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646517, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646518, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646519, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646520, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646521, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646522, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646523, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646524, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646525, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646526, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646527, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646528, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646529, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646530, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646531, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646532, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646533, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646534, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646535, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646536, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646537, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646538, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646539, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646540, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646541, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646542, 'HP:0032845', 'Focal aware epileptic spasm', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646543, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0000474', 'abnormal foregut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646544, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0003119', 'abnormal digestive system development', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646545, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0010352', 'gastrointestinal tract polyps', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646546, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0004547', 'esophageal ulcer', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646547, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0002138', 'abnormal hepatobiliary system morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646548, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0009705', 'abnormal midgut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646549, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0000467', 'abnormal esophagus morphology', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646550, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0003301', 'peptic ulcer', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646551, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0000462', 'abnormal digestive system morphology', 0.48, 5.838135946814261, 1.674008737871713, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646552, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0003943', 'abnormal hepatobiliary system development', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646553, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0000468', 'abnormal esophageal epithelium morphology', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646554, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0003300', 'gastrointestinal ulcer', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646555, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0003160', 'abnormal esophagus development', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646556, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0008786', 'abnormal hindgut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646557, 'HP:0033009', 'Increased fecal coproporphyrin 1', 'MP:0000477', 'abnormal intestine morphology', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(646558, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646559, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0003633', 'abnormal nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646560, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646561, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646562, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0006080', 'brain ischemia', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646563, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0002634', 'abnormal sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646564, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646565, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0013806', 'encephalopathy', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646566, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646567, 'HP:5200135', 'Delay in the acquisition of play skills', 'MP:0003880', 'abnormal central pattern generator function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(646568, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0013844', 'abnormal perichondrial ossification', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646569, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0000131', 'abnormal long bone epiphysis morphology', 0.4117647058823529, 6.382743560816355, 1.6211688761637475, 'UPHENO:0086956', 'abnormal long bone morphology'),
(646570, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0004686', 'decreased length of long bones', 0.46153846153846156, 6.930014923262251, 1.7884262428518094, 'UPHENO:0020041', 'abnormal long bone morphology'),
(646571, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0010876', 'decreased bone volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646572, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0003200', 'calcified joint', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646573, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0008151', 'increased diameter of long bones', 0.4375, 6.382743560816355, 1.6710626283467522, 'UPHENO:0086956', 'abnormal long bone morphology'),
(646574, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0006322', 'abnormal perichondrium morphology', 0.45454545454545453, 4.825104621810128, 1.4809555609639535, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646575, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0000133', 'abnormal long bone metaphysis morphology', 0.42424242424242425, 6.382743560816355, 1.6455487235443542, 'UPHENO:0086956', 'abnormal long bone morphology'),
(646576, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0010928', 'abnormal osteoid thickness', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646577, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.43333333333333335, 5.963591670916238, 1.6075518832675468, 'UPHENO:0076740', 'abnormal appendicular skeleton morphology'),
(646578, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0004214', 'abnormal long bone diaphysis morphology', 0.42424242424242425, 6.382743560816355, 1.6455487235443542, 'UPHENO:0086956', 'abnormal long bone morphology'),
(646579, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0003723', 'abnormal long bone morphology', 0.45161290322580644, 6.382743560816355, 1.697801328202477, 'UPHENO:0086956', 'abnormal long bone morphology'),
(646580, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0004695', 'increased length of long bones', 0.46153846153846156, 6.930014923262251, 1.7884262428518094, 'UPHENO:0020041', 'abnormal long bone morphology'),
(646581, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(646582, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0009345', 'abnormal trabecular bone thickness', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646583, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0010875', 'increased bone volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646584, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0008150', 'decreased diameter of long bones', 0.4375, 6.382743560816355, 1.6710626283467522, 'UPHENO:0086956', 'abnormal long bone morphology'),
(646585, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0005508', 'abnormal skeleton morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646586, 'HP:0003105', 'Protuberances at ends of long bones', 'MP:0004986', 'abnormal osteoblast morphology', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(646587, 'HP:0100263', 'Distal symphalangism', 'MP:0008730', 'fused phalanges', 0.44565217391304346, 11.33412877350486, 2.2474605952769933, 'UPHENO:0082665', 'abnormally fused bone element in digit with bone element in digit'),
(646588, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013133', 'pale limbs', 0.48, 5.844765229200882, 1.6749588980080745, 'UPHENO:0086635', 'abnormal limb morphology'),
(646589, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013069', 'limb wound', 0.4444444444444444, 5.844765229200882, 1.6117299510775347, 'UPHENO:0086635', 'abnormal limb morphology'),
(646590, 'HP:0001760', 'Abnormal foot morphology', 'MP:0006280', 'abnormal digit development', 0.46153846153846156, 5.844765229200882, 1.6424323279632769, 'UPHENO:0086635', 'abnormal limb morphology'),
(646591, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013149', 'macrodactyly', 0.4482758620689655, 6.296534486251748, 1.6800548874579881, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646592, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013082', 'autopod closed contusion', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646593, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013073', 'limb open laceration', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646594, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013071', 'limb open avulsion', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646595, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013080', 'autopod open laceration', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646596, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013075', 'limb closed contusion', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646597, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013076', 'autopod wound', 0.4642857142857143, 6.296534486251748, 1.7097926808458461, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646598, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013078', 'autopod open avulsion', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646599, 'HP:0001760', 'Abnormal foot morphology', 'MP:0000572', 'abnormal autopod morphology', 0.52, 6.296534486251748, 1.8094744907986156, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646600, 'HP:0001760', 'Abnormal foot morphology', 'MP:0030881', 'abnormal knee morphology', 0.5, 7.553673854641961, 1.943408584760544, 'UPHENO:0003070', 'abnormal leg'),
(646601, 'HP:0001760', 'Abnormal foot morphology', 'MP:0002109', 'abnormal limb morphology', 0.5, 5.844765229200882, 1.7094977667725808, 'UPHENO:0086635', 'abnormal limb morphology'),
(646602, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013072', 'limb open incision', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646603, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013074', 'limb open puncture', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646604, 'HP:0001760', 'Abnormal foot morphology', 'MP:0000556', 'abnormal hindlimb morphology', 0.52, 7.109295430960158, 1.9227151697792584, 'UPHENO:0086628', 'abnormal hindlimb morphology'),
(646605, 'HP:0001760', 'Abnormal foot morphology', 'MP:0012531', 'delayed limb development', 0.46153846153846156, 5.844765229200882, 1.6424323279632769, 'UPHENO:0086635', 'abnormal limb morphology'),
(646606, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013079', 'autopod open incision', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646607, 'HP:0001760', 'Abnormal foot morphology', 'MP:0012000', 'abnormal limb position', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646608, 'HP:0001760', 'Abnormal foot morphology', 'MP:0006279', 'abnormal limb development', 0.48, 5.844765229200882, 1.6749588980080745, 'UPHENO:0086635', 'abnormal limb morphology'),
(646609, 'HP:0001760', 'Abnormal foot morphology', 'MP:0009049', 'abnormal hallux morphology', 0.46875, 7.503859459499253, 1.8754823703890886, 'UPHENO:0081575', 'abnormal pes morphology'),
(646610, 'HP:0001760', 'Abnormal foot morphology', 'MP:0003800', 'monodactyly', 0.4482758620689655, 6.296534486251748, 1.6800548874579881, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646611, 'HP:0001760', 'Abnormal foot morphology', 'MP:0003855', 'abnormal forelimb zeugopod morphology', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646612, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013081', 'autopod open puncture', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646613, 'HP:0001760', 'Abnormal foot morphology', 'MP:0003856', 'abnormal hindlimb stylopod morphology', 0.5185185185185185, 7.553673854641961, 1.9790704324204877, 'UPHENO:0003070', 'abnormal leg'),
(646614, 'HP:0001760', 'Abnormal foot morphology', 'MP:0008909', 'supination', 0.5, 6.296534486251748, 1.77433571883279, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646615, 'HP:0001760', 'Abnormal foot morphology', 'MP:0031291', 'pes valgus', 0.5, 6.296534486251748, 1.77433571883279, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646616, 'HP:0001760', 'Abnormal foot morphology', 'MP:0011685', 'abnormal limb paddle morphology', 0.4444444444444444, 5.844765229200882, 1.6117299510775347, 'UPHENO:0086635', 'abnormal limb morphology'),
(646617, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013070', 'limb open abrasion', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(646618, 'HP:0001760', 'Abnormal foot morphology', 'MP:0000550', 'abnormal forelimb morphology', 0.46153846153846156, 5.844765229200882, 1.6424323279632769, 'UPHENO:0086635', 'abnormal limb morphology'),
(646619, 'HP:0001760', 'Abnormal foot morphology', 'MP:0000578', 'ulcerated paws', 0.5, 6.296534486251748, 1.77433571883279, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646620, 'HP:0001760', 'Abnormal foot morphology', 'MP:0003857', 'abnormal hindlimb zeugopod morphology', 0.5, 7.553673854641961, 1.943408584760544, 'UPHENO:0003070', 'abnormal leg'),
(646621, 'HP:0001760', 'Abnormal foot morphology', 'MP:0013077', 'autopod open abrasion', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646622, 'HP:0001760', 'Abnormal foot morphology', 'MP:0002110', 'abnormal digit morphology', 0.4642857142857143, 6.296534486251748, 1.7097926808458461, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(646623, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0013617', 'increased areal bone mineral density', 0.4857142857142857, 10.692263881549227, 2.2789000227950633, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(646624, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0000063', 'decreased bone mineral density', 0.42857142857142855, 10.340360727216375, 2.105132577489365, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646625, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0013613', 'abnormal volumetric bone mineral density', 0.45454545454545453, 10.340360727216375, 2.1679861546874633, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646626, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0021187', 'increased bone mineral density of vertebrae', 0.4146341463414634, 10.692263881549227, 2.1055587636026276, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(646627, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0013614', 'abnormal areal bone mineral density', 0.45454545454545453, 10.340360727216375, 2.1679861546874633, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646628, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0013616', 'decreased volumetric bone mineral density', 0.40540540540540543, 10.340360727216375, 2.0474467349983216, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646629, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0020009', 'abnormal bone mineral density of femur', 0.45454545454545453, 10.340360727216375, 2.1679861546874633, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646630, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0013615', 'increased volumetric bone mineral density', 0.4857142857142857, 10.692263881549227, 2.2789000227950633, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(646631, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0013618', 'decreased areal bone mineral density', 0.40540540540540543, 10.340360727216375, 2.0474467349983216, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646632, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0010119', 'abnormal bone mineral density', 0.46875, 10.340360727216375, 2.201600347674999, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646633, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0020011', 'increased bone mineral density of femur', 0.4857142857142857, 10.692263881549227, 2.2789000227950633, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(646634, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0020010', 'decreased bone mineral density of femur', 0.40540540540540543, 10.340360727216375, 2.0474467349983216, 'UPHENO:0084654', 'abnormal bone element mass density'),
(646635, 'HP:0005700', 'Increased bone density with cystic changes', 'MP:0000062', 'increased bone mineral density', 0.5151515151515151, 10.692263881549227, 2.346941826927098, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(646636, 'HP:0008176', 'Neonatal unconjugated hyperbilirubinemia', 'MP:0005344', 'increased circulating bilirubin level', 0.5, 15.192109768632433, 2.75609413560499, 'UPHENO:0068320', 'increased level of bilirubin IXalpha in blood'),
(646637, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646638, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646639, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646640, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008566', 'increased interferon-gamma secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646641, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646642, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646643, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002418', 'increased susceptibility to viral infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646644, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646645, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646646, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002471', 'abnormal complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646647, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008558', 'abnormal interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646648, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646649, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0012553', 'decreased serum complement activity', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646650, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646651, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008690', 'increased interleukin-23 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646652, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0012554', 'increased serum complement activity', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646653, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646654, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646655, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646656, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0012565', 'perivasculitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646657, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646658, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008747', 'abnormal T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646659, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008702', 'increased interleukin-5 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646660, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646661, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646662, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646663, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0031222', 'decreased CXCL10 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646664, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646665, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008672', 'increased interleukin-13 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646666, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646667, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646668, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008663', 'increased interleukin-12 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646669, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646670, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003777', 'lip inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646671, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646672, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003009', 'abnormal cytokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646673, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002406', 'increased susceptibility to infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646674, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646675, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003767', 'palate inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646676, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002419', 'abnormal innate immunity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646677, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646678, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646679, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646680, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646681, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646682, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646683, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646684, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001790', 'abnormal immune system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646685, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646686, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020155', 'enhanced humoral immune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646687, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646688, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008678', 'increased interleukin-16 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646689, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646690, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646691, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001835', 'abnormal antigen presentation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646692, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646693, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002499', 'chronic inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646694, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005001', 'abnormal clonal deletion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646695, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005044', 'sepsis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646696, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646697, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001844', 'autoimmune response', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646698, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003762', 'abnormal immune organ physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646699, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646700, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005087', 'decreased acute inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646701, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0009062', 'impaired lectin complement pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646702, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646703, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646704, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003726', 'decreased autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646705, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646706, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005043', 'defective assembly of class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646707, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0031223', 'increased CXCL10 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646708, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646709, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646710, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646711, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001800', 'abnormal humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646712, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646713, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005088', 'increased acute inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646714, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002498', 'abnormal acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646715, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003746', 'stomatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646716, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646717, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646718, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646719, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005399', 'increased susceptibility to fungal infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646720, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646721, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008667', 'decreased interleukin-12a secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646722, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001839', 'abnormal level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646723, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646724, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001819', 'abnormal immune cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646725, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646726, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646727, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646728, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646729, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646730, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646731, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646732, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646733, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001846', 'increased inflammatory response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646734, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008687', 'increased interleukin-2 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646735, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002500', 'granulomatous inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646736, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004829', 'increased anti-chromatin antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646737, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0009057', 'increased interleukin-21 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646738, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646739, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004751', 'increased length of allograft survival', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646740, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008684', 'increased interleukin-18 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646741, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0011762', 'renal/urinary system inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646742, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008711', 'increased interleukin-9 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646743, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646744, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646745, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646746, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003303', 'peritoneal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646747, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001837', 'defective assembly of class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646748, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646749, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008651', 'increased interleukin-1 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646750, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008666', 'increased interleukin-12a secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646751, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646752, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646753, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646754, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646755, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646756, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646757, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646758, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646759, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008564', 'increased interferon-beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646760, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0013942', 'enthesitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646761, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008699', 'increased interleukin-4 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646762, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646763, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646764, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646765, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008669', 'increased interleukin-12b secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646766, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008722', 'abnormal chemokine secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646767, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0030153', 'dental pulp inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646768, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004510', 'myositis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646769, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646770, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005042', 'abnormal level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646771, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646772, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008748', 'abnormal central T cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646773, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646774, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0031221', 'abnormal CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646775, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646776, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646777, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646778, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646779, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646780, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646781, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005000', 'abnormal immune tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646782, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646783, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008693', 'increased interleukin-23a secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646784, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0031066', 'cytokine storm', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646785, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646786, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646787, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005005', 'abnormal self tolerance', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646788, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008565', 'decreased interferon-beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646789, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008675', 'increased interleukin-15 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646790, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002410', 'decreased susceptibility to viral infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646791, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0011717', 'increased interleukin-8 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646792, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646793, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646794, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020154', 'impaired humoral immune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646795, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005025', 'abnormal response to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646796, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646797, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646798, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646799, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008694', 'decreased interleukin-23a secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646800, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646801, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646802, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646803, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646804, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646805, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0030132', 'periodontium inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646806, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002254', 'reproductive system inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646807, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646808, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005190', 'osteomyelitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646809, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646810, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646811, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646812, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003865', 'lymph node inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646813, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020142', 'increased anti-sperm antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646814, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646815, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646816, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003633', 'abnormal nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646817, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008562', 'increased interferon-alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646818, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646819, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002409', 'decreased susceptibility to infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646820, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020000', 'abnormal response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646821, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020386', 'adipose tissue inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646822, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646823, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002472', 'impaired complement alternative pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646824, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646825, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005363', 'decreased susceptibility to prion infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646826, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001845', 'abnormal inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646827, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646828, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646829, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646830, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646831, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646832, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646833, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646834, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646835, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008660', 'increased interleukin-10 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646836, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646837, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646838, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646839, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003278', 'esophageal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646840, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646841, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008744', 'abnormal B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646842, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008681', 'increased interleukin-17 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646843, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646844, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646845, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646846, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646847, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646848, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0030129', 'tongue inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646849, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646850, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646851, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002405', 'respiratory system inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646852, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646853, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646854, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646855, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646856, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646857, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646858, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001793', 'abnormal susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646859, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0003725', 'increased autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646860, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0014048', 'abnormal Peyers patch physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646861, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646862, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646863, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646864, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020001', 'decreased response to antigen', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646865, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008568', 'abnormal interleukin secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646866, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646867, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646868, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002420', 'abnormal adaptive immunity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646869, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005364', 'increased susceptibility to prion infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646870, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008555', 'abnormal interferon secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646871, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646872, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646873, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646874, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004752', 'decreased length of allograft survival', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646875, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646876, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646877, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646878, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646879, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646880, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646881, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646882, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646883, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646884, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646885, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0004796', 'increased anti-histone antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646886, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646887, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0013971', 'blood in lymph vessels', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646888, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646889, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646890, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646891, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646892, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001873', 'stomach inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646893, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008696', 'increased interleukin-3 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646894, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646895, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0005671', 'abnormal response to transplant', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646896, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0002473', 'impaired complement classical pathway', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646897, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008708', 'increased interleukin-7 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646898, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646899, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646900, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008705', 'increased interleukin-6 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646901, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0020002', 'increased response to antigen', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646902, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646903, 'HP:0031406', 'Abnormal cytokine signaling', 'MP:0001876', 'decreased inflammatory response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(646904, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0012545', 'syringomyelia', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646905, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0004996', 'abnormal CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646906, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014062', 'nervous system inclusion bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646907, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0006007', 'abnormal basal ganglion morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646908, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646909, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009023', 'abnormal spinal cord meninges morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646910, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014276', 'lobar holoprosencephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646911, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0004998', 'decreased CNS synapse formation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646912, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009678', 'abnormal spinal cord lateral column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646913, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646914, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0004203', 'abnormal cranial flexure morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646915, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014065', 'Lewy bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646916, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0008493', 'alpha-synuclein inclusion body', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646917, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009682', 'abnormal anterior corticospinal tract morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646918, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000783', 'abnormal forebrain morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646919, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0003214', 'neurofibrillary tangles', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646920, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0003861', 'abnormal nervous system development', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646921, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0008857', 'myelencephalic blebs', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646922, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0010892', 'increased oligodendrocyte progenitor number', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646923, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0005157', 'holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646924, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646925, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0010744', 'abnormal cervical flexure morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646926, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014278', 'semilobar holoprosencephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646927, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0004997', 'increased CNS synapse formation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646928, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000841', 'abnormal hindbrain morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646929, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009804', 'abnormal interventricular foramen morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646930, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0008025', 'brain vacuoles', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646931, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000830', 'abnormal diencephalon morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646932, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000955', 'abnormal spinal cord morphology', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646933, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0002184', 'abnormal innervation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646934, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0021002', 'brain lesion', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646935, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009677', 'abnormal spinal cord dorsal column morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646936, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000847', 'abnormal metencephalon morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646937, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000913', 'abnormal brain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646938, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009022', 'abnormal brain meninges morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646939, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0006108', 'abnormal hindbrain development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646940, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646941, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0013935', 'basal brain tissue herniation', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646942, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014066', 'Rosenthal fibers', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646943, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0001891', 'hydrocephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646944, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009679', 'abnormal spinal cord ventral column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646945, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0013934', 'supratentorial ventricles enlargement', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646946, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0002924', 'delayed CNS synapse formation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646947, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009686', 'abnormal spinal cord medial motor column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646948, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646949, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014067', 'Hirano bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646950, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009037', 'abnormal subarachnoid space development', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646951, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0005277', 'abnormal brainstem morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646952, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0012132', 'abnormal midbrain-hindbrain boundary morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646953, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009694', 'abnormal spinal cord commissure morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646954, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0008026', 'abnormal brain white matter morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646955, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646956, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0002653', 'abnormal ependyma morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646957, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646958, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646959, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0002152', 'abnormal brain morphology', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646960, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000822', 'abnormal brain ventricle morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646961, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000897', 'abnormal midbrain morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646962, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0001890', 'anencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646963, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0003232', 'abnormal forebrain development', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646964, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0020370', 'abnormal glymphatic system morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646965, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0003864', 'abnormal midbrain development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646966, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646967, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000778', 'abnormal nervous system tract morphology', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646968, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000914', 'exencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646969, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0001889', 'delayed brain development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646970, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0020452', 'abnormal axon radial sorting', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646971, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646972, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014063', 'Lafora bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646973, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000954', 'decreased oligodendrocyte progenitor number', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646974, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0000787', 'abnormal telencephalon morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646975, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0012260', 'encephalomeningocele', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646976, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0002778', 'meroanencephaly', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646977, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0006282', 'abnormal spinal cord dorsal horn morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646978, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014064', 'argyrophilic inclusion bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646979, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0004250', 'tau protein deposits', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646980, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0009032', 'abnormal subarachnoid cistern morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646981, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0005112', 'abnormal spinal cord ventral horn morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646982, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0003632', 'abnormal nervous system morphology', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646983, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014277', 'alobar holoprosencephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646984, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0004166', 'abnormal limbic system morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646985, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0013564', 'abnormal sensory circumventricular organ morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646986, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646987, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0014061', 'ethmocephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646988, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646989, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0012711', 'diplomyelia', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(646990, 'HP:0025459', 'Increased CSF/serum albumin ratio', 'MP:0005623', 'abnormal meninges morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(646991, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(646992, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(646993, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(646994, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0003866', 'abnormal defecation', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(646995, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(646996, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0003261', 'hematemesis', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(646997, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4482758620689655, 5.110459900932426, 1.5135705525872798, 'UPHENO:0002833', 'abnormal digestive system'),
(646998, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0005036', 'diarrhea', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(646999, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647000, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0003292', 'melena', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647001, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001666', 'abnormal intestinal absorption', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647002, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647003, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001663', 'abnormal digestive system physiology', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647004, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0010994', 'aerophagia', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647005, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0020147', 'abnormal defecation amount', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647006, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0008003', 'achlorhydria', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647007, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0009247', 'meteorism', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647008, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647009, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0003259', 'nausea', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647010, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001665', 'chronic diarrhea', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647011, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0000503', 'excessive digestive secretion', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647012, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647013, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0010377', 'abnormal gut flora balance', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647014, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0000505', 'decreased digestive secretion', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647015, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0006001', 'abnormal intestinal transit time', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647016, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0014202', 'abnormal intestinal epithelial transmembrane transport', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647017, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0000501', 'abnormal digestive secretion', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647018, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647019, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001664', 'abnormal digestion', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647020, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0005037', 'mucous diarrhea', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647021, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0011220', 'increased intestinal calcium absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647022, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647023, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0006002', 'abnormal small intestinal transit time', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647024, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0008001', 'hypochlorhydria', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647025, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0005342', 'abnormal intestinal lipid absorption', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647026, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647027, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0001671', 'abnormal vitamin absorption', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647028, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0011221', 'decreased intestinal calcium absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647029, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647030, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647031, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0006003', 'abnormal large intestinal transit time', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647032, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0008004', 'abnormal stomach pH', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647033, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0008002', 'hyperchlorhydria', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647034, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0008005', 'decreased stomach pH', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647035, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0003868', 'abnormal feces composition', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647036, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0010155', 'abnormal intestine physiology', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647037, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0008006', 'increased stomach pH', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647038, 'HP:0011470', 'Nasogastric tube feeding in infancy', 'MP:0003260', 'vomiting', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(647039, 'HP:0045053', 'Abnormality of the lumbosacral nerve plexus', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.41379310344827586, 8.67640993034839, 1.8947924930894937, 'UPHENO:0075899', 'abnormal somatic nervous system'),
(647040, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647041, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647042, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647043, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647044, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647045, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647046, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647047, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647048, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647049, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647050, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647051, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647052, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647053, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647054, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647055, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647056, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647057, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647058, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647059, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647060, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647061, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647062, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647063, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647064, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647065, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647066, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647067, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647068, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647069, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647070, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647071, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647072, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647073, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647074, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647075, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647076, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647077, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647078, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647079, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647080, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647081, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647082, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647083, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647084, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647085, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647086, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647087, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647088, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647089, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647090, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647091, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647092, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647093, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647094, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647095, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647096, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647097, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647098, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647099, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647100, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647101, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647102, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647103, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647104, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647105, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647106, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647107, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647108, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647109, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647110, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647111, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647112, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647113, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647114, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647115, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647116, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647117, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647118, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647119, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647120, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647121, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647122, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647123, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647124, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647125, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647126, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647127, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647128, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647129, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647130, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647131, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647132, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647133, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647134, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647135, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647136, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647137, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647138, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647139, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647140, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647141, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647142, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647143, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647144, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647145, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647146, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647147, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647148, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647149, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647150, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647151, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647152, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647153, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647154, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647155, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647156, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647157, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647158, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647159, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647160, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647161, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647162, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647163, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647164, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647165, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647166, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647167, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647168, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647169, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647170, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647171, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647172, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647173, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647174, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647175, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647176, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647177, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647178, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647179, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647180, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647181, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647182, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647183, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647184, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647185, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647186, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647187, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647188, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647189, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647190, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647191, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647192, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647193, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647194, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647195, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647196, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647197, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647198, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647199, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647200, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647201, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647202, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647203, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647204, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647205, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647206, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647207, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647208, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647209, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647210, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647211, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647212, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647213, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647214, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647215, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647216, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647217, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647218, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647219, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647220, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647221, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647222, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647223, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647224, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647225, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647226, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647227, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647228, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647229, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647230, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647231, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647232, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647233, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647234, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647235, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647236, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647237, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647238, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647239, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647240, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647241, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647242, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647243, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647244, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647245, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647246, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647247, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647248, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647249, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647250, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647251, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647252, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647253, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647254, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647255, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647256, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647257, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647258, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647259, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647260, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647261, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647262, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647263, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647264, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647265, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647266, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647267, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647268, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647269, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647270, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647271, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647272, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647273, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647274, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647275, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647276, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647277, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647278, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647279, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647280, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647281, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647282, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647283, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647284, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647285, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647286, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647287, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647288, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647289, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647290, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647291, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647292, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647293, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647294, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647295, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647296, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647297, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647298, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647299, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647300, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647301, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647302, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647303, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647304, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647305, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647306, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647307, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647308, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647309, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647310, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647311, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647312, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647313, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647314, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647315, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647316, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647317, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647318, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647319, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647320, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647321, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647322, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647323, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647324, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647325, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647326, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647327, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647328, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647329, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647330, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647331, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647332, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647333, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647334, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647335, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647336, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647337, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647338, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647339, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647340, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647341, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647342, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647343, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647344, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647345, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647346, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647347, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647348, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647349, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647350, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647351, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647352, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647353, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647354, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647355, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647356, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647357, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647358, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647359, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647360, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647361, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647362, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647363, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647364, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647365, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647366, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647367, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647368, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647369, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647370, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647371, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647372, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647373, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647374, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647375, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647376, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647377, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647378, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647379, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647380, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647381, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647382, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647383, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647384, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647385, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647386, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647387, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647388, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647389, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647390, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647391, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647392, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647393, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647394, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647395, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647396, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647397, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647398, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647399, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647400, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647401, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647402, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647403, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647404, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647405, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647406, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647407, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647408, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647409, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647410, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647411, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647412, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647413, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647414, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647415, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647416, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647417, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647418, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647419, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647420, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647421, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647422, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647423, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647424, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647425, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647426, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647427, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647428, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647429, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647430, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647431, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647432, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647433, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647434, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647435, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647436, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647437, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647438, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647439, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647440, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647441, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647442, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647443, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647444, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647445, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647446, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647447, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647448, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647449, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647450, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647451, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647452, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647453, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647454, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647455, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647456, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647457, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647458, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647459, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647460, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647461, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647462, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647463, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647464, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647465, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647466, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647467, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647468, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647469, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647470, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647471, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647472, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647473, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647474, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647475, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647476, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647477, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647478, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647479, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647480, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647481, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647482, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647483, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647484, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647485, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647486, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647487, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647488, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647489, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647490, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647491, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647492, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647493, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647494, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647495, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647496, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647497, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647498, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647499, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647500, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647501, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647502, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647503, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647504, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647505, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647506, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647507, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647508, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647509, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647510, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647511, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647512, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647513, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647514, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647515, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647516, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647517, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647518, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647519, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647520, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647521, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647522, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647523, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647524, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647525, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647526, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647527, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647528, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647529, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647530, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647531, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647532, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647533, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647534, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647535, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647536, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647537, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647538, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647539, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647540, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647541, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647542, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647543, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647544, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647545, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647546, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647547, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647548, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647549, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647550, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647551, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647552, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647553, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647554, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647555, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647556, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647557, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647558, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647559, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647560, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647561, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647562, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647563, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647564, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647565, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647566, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647567, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647568, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647569, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647570, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647571, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647572, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647573, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647574, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647575, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647576, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647577, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647578, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647579, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647580, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647581, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647582, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647583, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647584, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647585, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647586, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647587, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647588, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647589, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647590, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647591, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647592, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647593, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647594, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647595, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647596, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647597, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647598, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647599, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647600, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647601, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647602, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647603, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647604, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647605, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647606, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647607, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647608, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647609, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647610, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647611, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647612, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647613, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647614, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647615, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647616, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647617, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647618, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647619, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647620, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647621, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647622, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647623, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647624, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647625, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647626, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647627, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647628, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647629, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647630, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647631, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647632, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647633, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647634, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647635, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647636, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647637, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647638, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647639, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647640, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647641, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647642, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647643, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647644, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647645, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647646, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647647, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647648, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647649, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647650, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647651, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647652, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647653, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647654, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647655, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647656, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647657, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647658, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647659, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647660, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647661, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647662, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647663, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647664, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647665, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647666, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647667, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647668, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647669, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647670, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647671, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647672, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647673, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647674, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647675, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647676, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647677, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647678, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647679, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647680, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647681, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647682, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647683, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647684, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647685, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647686, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647687, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647688, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647689, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647690, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647691, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647692, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647693, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647694, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647695, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647696, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647697, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647698, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647699, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647700, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647701, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647702, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647703, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647704, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647705, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647706, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647707, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647708, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647709, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647710, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647711, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647712, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647713, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647714, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647715, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647716, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647717, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647718, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647719, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647720, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647721, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647722, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647723, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647724, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647725, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647726, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647727, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647728, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647729, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647730, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647731, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647732, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647733, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647734, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647735, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647736, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647737, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647738, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647739, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647740, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647741, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647742, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647743, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647744, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647745, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647746, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647747, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647748, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647749, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647750, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647751, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647752, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647753, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647754, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647755, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647756, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647757, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647758, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647759, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647760, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647761, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647762, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647763, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647764, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647765, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647766, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647767, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647768, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647769, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647770, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647771, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647772, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647773, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647774, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647775, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647776, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647777, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647778, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647779, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647780, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647781, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647782, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647783, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647784, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647785, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647786, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647787, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(647788, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647789, 'HP:0034142', 'Anti-nuclear matrix protein-2 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(647790, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0001296', 'macrophthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(647791, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0002699', 'abnormal vitreous body morphology', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(647792, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0001297', 'microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(647793, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0014087', 'retrolental blood', 0.40816326530612246, 7.832360208310102, 1.7879825831583462, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(647794, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0006225', 'ocular rupture', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(647795, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.4166666666666667, 7.832360208310102, 1.806511394962459, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(647796, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0006200', 'vitreous body deposition', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(647797, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0003381', 'vitreal fibroplasia', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(647798, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0002697', 'abnormal eye size', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(647799, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0006209', 'calcified intraocular region', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(647800, 'HP:0030617', 'Abnormal OCT-measured foveal thickness', 'MP:0005176', 'eyelids fail to open', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(647801, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0003528', 'enlarged vulva', 0.4318181818181818, 9.95849009187273, 2.0737061231348237, 'UPHENO:0002595', 'abnormal external genitalia'),
(647802, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0008725', 'enlarged heart atrium', 0.4090909090909091, 10.843381614401354, 2.1061644860397535, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(647803, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0004556', 'enlarged allantois', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647804, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0001268', 'barrel chest', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647805, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0001150', 'enlarged scrotum', 0.40425531914893614, 9.95849009187273, 2.0064328023463753, 'UPHENO:0002595', 'abnormal external genitalia'),
(647806, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0009200', 'enlarged external male genitalia', 0.4318181818181818, 9.95849009187273, 2.0737061231348237, 'UPHENO:0002595', 'abnormal external genitalia'),
(647807, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0013328', 'visceromegaly', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647808, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0001264', 'increased body size', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647809, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0000655', 'dilated sex gland', 0.42857142857142855, 7.392828147110509, 1.7799873370870418, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(647810, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0001267', 'enlarged chest', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647811, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0012160', 'expanded anterior visceral endoderm', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647812, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0008772', 'increased heart ventricle size', 0.4090909090909091, 10.843381614401354, 2.1061644860397535, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(647813, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0031094', 'organomegaly', 0.45714285714285713, 5.9605885577567275, 1.6507090850740274, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647814, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0010944', 'respiratory epithelium hypertrophy', 0.43902439024390244, 10.843381614401354, 2.181859070023657, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(647815, 'HP:0003247', 'Overgrowth of external genitalia', 'MP:0010875', 'increased bone volume', 0.425, 10.365561281341517, 2.0988957917367275, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(647816, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0005475', 'abnormal circulating thyroxine level', 0.421875, 11.700256672302759, 2.2217213559822766, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(647817, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.44642857142857145, 9.920646740728058, 2.104485721526934, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647818, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030669', 'abnormal circulating phenylalanine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647819, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0005328', 'abnormal circulating creatinine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647820, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030680', 'abnormal circulating hydroxyproline level', 0.4426229508196721, 11.700256672302759, 2.275698164002029, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(647821, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030626', 'decreased circulating cysteine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647822, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030672', 'abnormal circulating alanine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647823, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030637', 'abnormal circulating taurine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647824, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030625', 'increased circulating cysteine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647825, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030708', 'abnormal circulating glutamine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647826, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0006076', 'abnormal circulating homocysteine level', 0.46551724137931033, 11.700256672302759, 2.3338104484983884, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(647827, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030660', 'abnormal circulating arginine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647828, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030666', 'abnormal circulating proline level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647829, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030652', 'abnormal circulating glutathione level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647830, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.46296296296296297, 9.920646740728058, 2.143103359522429, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647831, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0003977', 'abnormal circulating carnitine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647832, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030643', 'abnormal circulating methionine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647833, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030654', 'abnormal circulating glycine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647834, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030726', 'abnormal circulating valine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647835, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030714', 'abnormal circulating isoleucine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647836, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0013722', 'abnormal circulating tyrosine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647837, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030717', 'abnormal circulating lysine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647838, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030649', 'abnormal circulating ornithine level', 0.45, 11.700256672302759, 2.294583949768725, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(647839, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0020835', 'abnormal circulating citrulline level', 0.46551724137931033, 11.700256672302759, 2.3338104484983884, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(647840, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.45454545454545453, 9.920646740728058, 2.1235312293792896, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647841, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030686', 'abnormal circulating cystathionine level', 0.45, 11.700256672302759, 2.294583949768725, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(647842, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0011651', 'abnormal circulating histidine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647843, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030702', 'abnormal circulating threonine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647844, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030749', 'abnormal circulating leucine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647845, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.44642857142857145, 9.920646740728058, 2.104485721526934, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647846, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0010063', 'abnormal circulating creatine level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647847, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0005476', 'abnormal circulating triiodothyronine level', 0.4153846153846154, 11.700256672302759, 2.2045649497635043, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(647848, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030693', 'abnormal circulating serine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647849, 'HP:0033301', 'Elevated circulating 1-methylhistidine concentration', 'MP:0030738', 'abnormal circulating glutamic acid level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(647850, 'HP:0033176', 'Submandibular lymph node enlargement', 'MP:0010200', 'enlarged lymphatic vessel', 0.425531914893617, 9.906707549770184, 2.0531975633009014, 'UPHENO:0075774', 'abnormal lymphatic part of lymphoid system'),
(647851, 'HP:0033176', 'Submandibular lymph node enlargement', 'MP:0004106', 'lymphatic vessel hyperplasia', 0.42857142857142855, 10.052558416233639, 2.0756298613295647, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(647852, 'HP:0033176', 'Submandibular lymph node enlargement', 'MP:0008102', 'lymph node hyperplasia', 0.46938775510204084, 14.384754846574829, 2.598466429478542, 'UPHENO:0083593', 'lymph node hyperplasia'),
(647853, 'HP:0033176', 'Submandibular lymph node enlargement', 'MP:0031094', 'organomegaly', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(647854, 'HP:0033176', 'Submandibular lymph node enlargement', 'MP:0000702', 'enlarged lymph nodes', 0.4375, 13.285219173023913, 2.410867766634653, 'UPHENO:0001209', 'increased size of the lymph node'),
(647855, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0008978', 'abnormal vagina weight', 0.4375, 11.78271883249473, 2.2704491822580932, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647856, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0003537', 'hydrometrocolpos', 0.4186046511627907, 11.78271883249473, 2.2208784087891216, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647857, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0001142', 'abnormal vagina orifice morphology', 0.4090909090909091, 11.78271883249473, 2.1954961076594612, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647858, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0003536', 'vagina dryness', 0.4222222222222222, 11.78271883249473, 2.2304541531436044, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647859, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0003534', 'blind vagina', 0.4186046511627907, 11.78271883249473, 2.2208784087891216, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647860, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0009063', 'abnormal oviduct size', 0.43478260869565216, 9.668547812575419, 2.050296671277155, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647861, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0008983', 'small vagina', 0.42857142857142855, 11.78271883249473, 2.247161908385273, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647862, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0003533', 'bifid vagina', 0.4117647058823529, 11.78271883249473, 2.202659246128791, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647863, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0009708', 'vaginal septum', 0.42857142857142855, 11.78271883249473, 2.247161908385273, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647864, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0003531', 'abnormal vagina development', 0.4090909090909091, 11.78271883249473, 2.1954961076594612, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647865, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0004895', 'vagina atrophy', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647866, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0004902', 'abnormal uterus size', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647867, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0008982', 'vagina hyperplasia', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647868, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0009225', 'abnormal uterine cervix size', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647869, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0013398', 'uterus fibrosis', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647870, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0008981', 'enlarged vagina', 0.42857142857142855, 11.78271883249473, 2.247161908385273, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647871, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0008977', 'abnormal vagina size', 0.4666666666666667, 11.78271883249473, 2.344909832345558, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647872, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0001139', 'abnormal vagina morphology', 0.42857142857142855, 11.78271883249473, 2.247161908385273, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647873, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0003568', 'uterus atresia', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647874, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0008984', 'vagina hypoplasia', 0.4339622641509434, 15.192109768632433, 2.5676452933427925, 'UPHENO:0080131', 'aplasia or hypoplasia of vagina'),
(647875, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0001144', 'vagina atresia', 0.4375, 11.78271883249473, 2.2704491822580932, 'UPHENO:0076734', 'abnormal vagina morphology'),
(647876, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0009065', 'abnormal oviduct weight', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647877, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0009209', 'abnormal internal female genitalia morphology', 0.4146341463414634, 9.668547812575419, 2.002226278078687, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647878, 'HP:0011026', 'Aplasia/Hypoplasia of the vagina', 'MP:0003571', 'uterus rupture', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(647879, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647880, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002337', 'abnormal whole-body plethysmography', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647881, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002311', 'abnormal inspiratory capacity', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647882, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002133', 'abnormal respiratory system physiology', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647883, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0001942', 'abnormal lung volume', 0.4186046511627907, 8.526773851447254, 1.8892716039863309, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647884, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002313', 'abnormal tidal volume', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647885, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002309', 'abnormal vital capacity', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647886, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002306', 'abnormal functional residual capacity', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647887, 'HP:0008747', 'Cartilaginous ossification of larynx', 'MP:0002308', 'abnormal residual volume', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(647888, 'HP:0100827', 'Lymphocytosis', 'MP:0012362', 'increased large unstained cell number', 0.4155844155844156, 11.126020578174659, 2.1503024809921274, 'UPHENO:0085451', 'abnormally increased number of lymphocyte'),
(647889, 'HP:0100827', 'Lymphocytosis', 'MP:0000218', 'increased leukocyte cell number', 0.4057971014492754, 10.645215308744795, 2.0784122585743403, 'UPHENO:0085943', 'abnormally increased number of leukocyte in the independent continuant'),
(647890, 'HP:0100827', 'Lymphocytosis', 'MP:0005013', 'increased lymphocyte cell number', 0.4266666666666667, 11.126020578174659, 2.1787845495492486, 'UPHENO:0085451', 'abnormally increased number of lymphocyte'),
(647891, 'HP:0200146', 'Mucoid extracellular matrix accumulation', 'MP:0012562', 'blood vessel degeneration', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647892, 'HP:0200146', 'Mucoid extracellular matrix accumulation', 'MP:0000265', 'blood vessel atresia', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647893, 'HP:0002300', 'Mutism', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647894, 'HP:0002300', 'Mutism', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647895, 'HP:0002300', 'Mutism', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647896, 'HP:0002300', 'Mutism', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647897, 'HP:0002300', 'Mutism', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647898, 'HP:0002300', 'Mutism', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647899, 'HP:0002300', 'Mutism', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647900, 'HP:0002300', 'Mutism', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647901, 'HP:0002300', 'Mutism', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647902, 'HP:0002300', 'Mutism', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647903, 'HP:0002300', 'Mutism', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647904, 'HP:0002300', 'Mutism', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647905, 'HP:0002300', 'Mutism', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647906, 'HP:0002300', 'Mutism', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647907, 'HP:0002300', 'Mutism', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647908, 'HP:0002300', 'Mutism', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647909, 'HP:0002300', 'Mutism', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647910, 'HP:0002300', 'Mutism', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647911, 'HP:0002300', 'Mutism', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647912, 'HP:0002300', 'Mutism', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647913, 'HP:0002300', 'Mutism', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647914, 'HP:0002300', 'Mutism', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647915, 'HP:0002300', 'Mutism', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647916, 'HP:0002300', 'Mutism', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647917, 'HP:0002300', 'Mutism', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647918, 'HP:0002300', 'Mutism', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647919, 'HP:0002300', 'Mutism', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647920, 'HP:0002300', 'Mutism', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647921, 'HP:0002300', 'Mutism', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647922, 'HP:0002300', 'Mutism', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647923, 'HP:0002300', 'Mutism', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647924, 'HP:0002300', 'Mutism', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647925, 'HP:0002300', 'Mutism', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647926, 'HP:0002300', 'Mutism', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647927, 'HP:0002300', 'Mutism', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647928, 'HP:0002300', 'Mutism', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647929, 'HP:0002300', 'Mutism', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647930, 'HP:0002300', 'Mutism', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647931, 'HP:0002300', 'Mutism', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647932, 'HP:0002300', 'Mutism', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647933, 'HP:0002300', 'Mutism', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647934, 'HP:0002300', 'Mutism', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647935, 'HP:0002300', 'Mutism', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647936, 'HP:0002300', 'Mutism', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647937, 'HP:0002300', 'Mutism', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647938, 'HP:0002300', 'Mutism', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647939, 'HP:0002300', 'Mutism', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647940, 'HP:0002300', 'Mutism', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647941, 'HP:0002300', 'Mutism', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647942, 'HP:0002300', 'Mutism', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647943, 'HP:0002300', 'Mutism', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647944, 'HP:0002300', 'Mutism', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647945, 'HP:0002300', 'Mutism', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647946, 'HP:0002300', 'Mutism', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647947, 'HP:0002300', 'Mutism', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647948, 'HP:0002300', 'Mutism', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647949, 'HP:0002300', 'Mutism', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647950, 'HP:0002300', 'Mutism', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647951, 'HP:0002300', 'Mutism', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647952, 'HP:0002300', 'Mutism', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647953, 'HP:0002300', 'Mutism', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647954, 'HP:0002300', 'Mutism', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647955, 'HP:0002300', 'Mutism', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647956, 'HP:0002300', 'Mutism', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647957, 'HP:0002300', 'Mutism', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647958, 'HP:0002300', 'Mutism', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647959, 'HP:0002300', 'Mutism', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647960, 'HP:0002300', 'Mutism', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647961, 'HP:0002300', 'Mutism', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647962, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0012562', 'blood vessel degeneration', 0.4358974358974359, 6.970522647367627, 1.7431101367534283, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647963, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0006133', 'calcified artery', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647964, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0004938', 'dilated vasculature', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647965, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0000265', 'blood vessel atresia', 0.4358974358974359, 6.970522647367627, 1.7431101367534283, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647966, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0002725', 'abnormal vein morphology', 0.4166666666666667, 8.904397389082982, 1.9261790100571068, 'UPHENO:0086792', 'abnormal vein morphology'),
(647967, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0013813', 'dilated hepatic portal vein', 0.40425531914893614, 9.288227922896251, 1.9377346421268533, 'UPHENO:0019766', 'abnormal vein morphology'),
(647968, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0020327', 'abnormal capillary branching pattern', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647969, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0014264', 'abnormal perivascular vein cell coverage', 0.40540540540540543, 8.904397389082982, 1.899971271733344, 'UPHENO:0086792', 'abnormal vein morphology'),
(647970, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0006136', 'varicose veins', 0.40540540540540543, 8.904397389082982, 1.899971271733344, 'UPHENO:0086792', 'abnormal vein morphology'),
(647971, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0006137', 'venoocclusion', 0.4634146341463415, 9.288227922896251, 2.074680877811525, 'UPHENO:0019766', 'abnormal vein morphology'),
(647972, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0013811', 'abnormal orbital vein morphology', 0.40540540540540543, 8.904397389082982, 1.899971271733344, 'UPHENO:0086792', 'abnormal vein morphology'),
(647973, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0013864', 'enlarged paraumbilical vein', 0.4418604651162791, 9.288227922896251, 2.0258580182522534, 'UPHENO:0019766', 'abnormal vein morphology'),
(647974, 'HP:0002642', 'Arteriovenous fistulas of celiac and mesenteric vessels', 'MP:0003719', 'abnormal pericyte morphology', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(647975, 'HP:0004592', 'Thoracic platyspondyly', 'MP:0011175', 'platyspondylia', 0.4838709677419355, 15.384754846574829, 2.7284127649761123, 'UPHENO:0041185', 'flattened vertebra'),
(647976, 'HP:0004592', 'Thoracic platyspondyly', 'MP:0021136', 'abnormal vertebrae shape', 0.4067796610169492, 12.637520916954795, 2.2673082001998486, 'UPHENO:0041156', 'shape vertebra'),
(647977, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647978, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647979, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647980, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647981, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647982, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647983, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647984, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647985, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647986, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647987, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647988, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(647989, 'HP:0032785', 'Focal aware autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
